Xeris Biopharma

Biopharmaceutical company developing and commercializing ready-to-use injectable and infusible drug formulations using proprietary XeriSol and XeriJect technologies. Publicly traded on NASDAQ (XERS).

Location
Chicago, Illinois, USA
Founded
2005
Investors
1
Categories
biopharmaceuticals, drug-delivery, biotech, diabetes, public-company

Investors

NameLocationTypeStagesPortfolio
OMX VenturesSan Francisco, California, USAbiotech-focused
seedseries-a
23